February 26, 2015
A New York federal judge on Thursday declined to review a suit against Eli Lilly & Co. over the labeling of its antidepressant Cymbalta that allegedly downplays its withdrawal symptoms, finding that the plaintiff had not introduced any new evidence that warranted a new look at the case.
December 10, 2014
The U.S. Judicial Panel on Multidistrict Litigation on Wednesday rejected a bid by plaintiffs to consolidate more than two dozen suits over Eli Lilly & Co.'s antidepressant Cymbalta, which they claim causes serious health problems the drugmaker misled consumers about.
November 07, 2014
A New York federal judge on Friday ruled Eli Lilly & Co.'s label for antidepressant drug Cymbalta adequately warned doctors about possible withdrawal symptoms and tossed a suit claiming the label was inaccurate, potentially hurting the plaintiffs' chances to consolidate more than two dozen similar cases in multidistrict litigation.
September 18, 2014
Eli Lilly & Co. on Wednesday sought early dismissal of a suit alleging it failed to warn a New York man he would suffer negative withdrawal effects when he stopped taking the antidepressant Cymbalta, hoping to moot more than two dozen similar cases in proposed multidistrict litigation.